¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Acute hepatitis B without delta- agent with hepatic coma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • hepatitis A
    AÇü°£¿°
  • hepatitis B
    BÇü°£¿°
  • hepatitis B core antigen
    BÇü°£¿°ÇÙ½ÉÇ׿ø
  • hepatitis B surface antigen
    BÇü°£¿°Ç¥¸éÇ׿ø
  • hepatitis B vaccine
    BÇü°£¿°¹é½Å
  • hepatitis C
    CÇü°£¿°
  • hepatitis contagiosa canis
    °³Á¢Ã˰¨¿°°£¿°
  • hepatitis D
    DÇü°£¿°
  • hepatitis E
    EÇü°£¿°
  • hepatitis E virus
    EÇü°£¿°¹ÙÀÌ·¯½º
  • hepatitis F
    FÇü°£¿°
  • hepatitis G virus
    GÇü°£¿°¹ÙÀÌ·¯½º
  • halothane hepatitis
    ÇÒ·Îź°£¿°
  • infantile hepatitis
    ¿µ¾Æ°£¿°
  • infectious hepatitis
    Àü¿°¼º°£¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • hepatic stupor
    °£È¥¹Ì
  • hepatic sulfur
    °£È²
  • hepatic triad
    °£¼¼µ¿ÀÌ
  • hepatic vein
    °£Á¤¸Æ
  • hepatic dissociation jaundice
    °£Çظ®È²´Þ
  • hepatic venous wedge pressure
    Æó»ö°£Á¤¸Æ¾Ð
  • massive hepatic necrosis
    ±¤¹üÀ§°£±«»ç
  • subacute hepatic necrosis
    ¾Æ±Þ¼º°£±«»ç
  • occluded hepatic portal pressure
    Â÷´Ü°£¹®¸Æ¾Ð
  • alcoholic hepatitis
    ¾ËÄڿ𣿰
  • amebic hepatitis
    ¾Æ¸Þ¹Ù°£¿°
  • anicteric hepatitis
    ¹«È²´Þ°£¿°
  • autoimmune hepatitis
    (¢¡chronic active hepatitis) ¸¸¼ºÈ°µ¿°£¿°
  • hepatitis B core antigen
    ºñÇü°£¿°ÇÙ½ÉÇ׿ø
  • hepatitis B surface antigen
    ºñÇü°£¿°Ç¥¸éÇ׿ø
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • Parvovirus-like agent
    ÆÄº¸¹ÙÀÌ·¯½º¾ç º´¿øÃ¼
  • Pittsburgh pneumonia [agent]
    ÇÇÃ÷¹ö±×Æó·Å(¿øÀÎü), ·¹Áö¿À³Ú¶óÁõ(¿øÀÎü)
  • addition agent
    ÷°¡Á¦(ôÕÊ¥ð¥).
  • alpha-sympathomimetic agent
    ¾ËÆÄ±³°¨½Å°æÀ¯»çÀÛ¿ëÁ¦
  • anesthetic agent
    ¸¶Ãë¾à, ¸¶ÃëÁ¦.
  • anorectic agent
    ½Ä¿å°¨ÅðÁ¦(ãÝé¯Êõ÷Üð¥).
  • anorexiant =anorectic agent
    ½Ä¿å°¨ÅðÁ¦(ãÝé¯Êõ÷Üð¥), ½Ä¿å¾ïÁ¦Á¦.
  • anorexigenic agent
    ½Ä¿å¾ïÁ¦Á¦.
  • anti-inflammatory agent
    Ç׿°Áõ¾à(ù÷æúñøå·).
  • antiallergic agent
    Ç׾˷¹¸£±â¾à.
  • antiallergic agent =a. drug
    Ç׾˷¹¸£±â¾à.
  • antianticholinesterase agent
    Ç×-Ç×Äݸ°¿¡½ºÅ×¶ó¾ÆÁ¦.
  • antiarrhythmic agent
    Ç׺ÎÁ¤¸ÆÁ¦<¾à>.
  • antiarrhythmic agent =a. drug
    Ç׺ÎÁ¤¸ÆÁ¦<¾à>.
  • antiasthmatic agent =antasthmatic
    Ç×õ½Ä¾à(ù÷ô·ãÓå·).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • antigen, hepatitis B surface
    BÇü °£¿°¹ÙÀÌ·¯½º Ç¥¸éÇ׿ø
  • autoimmune hepatitis
    ÀÚ°¡¸é¿ª¼º °£¿°
  • canine hepatitis virus
    °³°£¿°¹ÙÀÌ·¯½º
  • cholestatic hepatitis
    ´ãÁó¿ïü¼º °£¿°, ´ãÁóÁ¤Ã¼¼º °£¿°.
  • chronic active hepatitis
    ¸¸¼ºÈ°µ¿¼º °£¿°(¡­ÊÜæú).
  • chronic active hepatitis
    ¸¸¼º Ȱµ¿¼º °£¿°
  • chronic hepatitis
    ¸¸¼º °£¿°
  • chronic hepatitis
    ¸¸¼º°£¿°
  • chronic hepatitis B
    ¸¸¼º BÇü °£¿°
  • chronic persistent hepatitis
    ¸¸¼º Áö¼Ó¼º °£¿°
  • drug-induced hepatitis
    ¾à¹°¼º °£¿°(¡­°£¿°).
  • drug-induced hepatitis
    ¾à¹° [¼ÒÈ­]¾à¹°¼º °£¿°(¡­ÊÜæú).
  • drug-induced hepatitis
    ¾à¹° ¼ÒÈ­¾à¹°¼º °£¿°(¡­ÊÜæú).
  • epidemic hepatitis
    À¯Ç༺ °£¿°.
  • epizootic hepatitis
    µ¿¹°À¯Ç༺ °£¿°.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
GCS general clinical services; Gianotti-Crosti syndrome; Glasgow Coma Scale; glucocorticosteroid; glutam...
HHNC hyperosmolar nonketotic diabetic coma
HHNK hyperglycemic hyperosmoler nonketotic [coma]
HNC hypernephroma cell; hyperosmolar nonketotic coma; hypothalamoneurohypophyseal complex
HNKC hyperosmolar nonketotic coma
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
CPA cryoprotective agent
AAH Acute alcoholic hepatitis
AH Acute hepatitis
AH-B acute hepatitis B
AVH acute viral hepatitis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • beta-adrenergic blocking agent
    º£Å¸ ¾Æµå·¹³¯¸°¼º Â÷´ÜÁ¦
  • bleaching agent
    Ç¥¹éÁ¦
    ¿°·á³ª »ö±òÀ» »©³»´Â È­ÇÐÀû ¾àÁ¦.
  • bonding agent
    °áÇÕÁ¦, Á¢ÂøÁ¦, º»µùÁ¦
    Ä¡Áú°ú ÇÇÁ¢ÀÛ¹°°úÀÇ »çÀÌ¿¡ °³Àç½ÃÄÑ, ¾çÀÚ¸¦ Á¢ÇÕ½ÃŰ´Â Á¢ÇÕÁ¦.
  • buffering agent
    ¿ÏÃæÁ¦
  • bulking agent
    ÃæÀüÁ¦
  • carcinoclastic agent
    Á¦¾Ï ¾à, Ç×¾Ï ¾à
    µ¿ÀǾî=carcinostatic agent.
  • carcinostatic agent
    Á¦¾Ï ¾à
    ¾Ï ¼¼Æ÷ÀÇ Áõ½ÄÀ» ¾ïÁ¦ÇÏ´Â ¼ºÁúÀ» °¡Áø ¾à¹°.
  • cardioactive agent
    ½É ÀÛ¿ë ¾à, ½ÉÀå ÀÛ¿ë ¾à
    ½ÉÀå¿¡ ´ëÇÑ ÀÛ¿ë È¿°ú ¶Ç´Â Ȱ¼º È¿°ú¸¦ °¡Áö´Â ¾à¹°.
  • cariogenic agent
    ¿ì½Ä À¯¹ß ¿äÀÎ
  • causative agent
    º´¿øÃ¼, ¿øÀÎ ¹°Áú
  • chelating agent
    ŰÀÏ·¹ÀÌÆ® ¾à, ų·¹ÀÌÆ®Á¦
    ±Ý¼Ó À̿°ú °áÇÕÇÏ¿© È­ÇÕ¹°À» »ý¼ºÇÏ´Â ´Ù ¹èÀ§ÀÚ¸¦ °®´Â È­ÇÐ ¹°Áú.
  • chemotherapeutic agent
    È­ÇÐ ¿ä¹ýÁ¦
  • cholinergic blocking agent
    Ç×Äݸ°¾à, Äݸ°¼º Â÷´ÜÁ¦
  • competitive agent
    °æÇÕÁ¦
  • compounding agent
    ¹èÇÕÁ¦, Á¶ÇÕÁ¦
    µ¿ÀǾî=com
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
hepatic necrosis A severe and rapidly progressive form of hepatitis accompanied by hepatocellular death and the signs and symptoms of hepatic failure. May be a complication of hepatitis B, C or D.
(27 Sep 1997)
hepatic obstruction <gastroenterology> A condition that results in liver enlargement and can occur either by blockage of the hepatic veins or by blockage of the common bile duct (drains bile from the liver).
(27 Sep 1997)
hepatic plexus An unpaired autonomic plexus lying on the hepatc artery and its branches in the liver.
Synonym: plexus hepaticus.
(05 Mar 2000)
hepatic porphyria A category of porphyria that includes porphyria cutanea tarda, variegate porphyria, and coproporphyria.
Synonym: porphyria hepatica.
(05 Mar 2000)
hepatic portal system A venous portal system in which the portal vein receives blood via its tributaries from the capillaries of most of the abdominal viscera and drains it into the hepatic sinusoids.
(05 Mar 2000)
hepatic portal vein <anatomy, vein> A large vein that carries blood from the stomach and intestines to the liver.
(09 Oct 1997)
hepatic prominence The conspicuous external bulge appearing dorsocaudal to the cardiac prominence on the body of the human embryo at about the fourth week, indicating the precocious development of the liver.
(05 Mar 2000)
hepatic segments Territories of the liver with independent portobilioarterial distribution or independent venous drainage. The naming of segments in the NA is based upon the portobilioarterial distribution.
See: anterior segment, lateral segment, medial segment, posterior segment.
Synonym: segmenta hepatis, segments of liver.
(05 Mar 2000)
hepatic steatosis <radiology> Hyperalimentation, diabetes, Cushing disease, steroids, obesity, previous jejunal bypass, Reye syndrome, kwashiorkor, malnutrition (EtOH, chemo, RT), Crohn disease
(12 Dec 1998)
hepatic transplant <surgery> Surgery to replace a disease liver with a healthy one from a donor.
Over 1,000 are performed each year in the us. This procedure is technically quite difficult, since both vessels and biliary tract must be reattached to the new liver.
most often indicated in those with long-term chronic hepatitis or congenital liver defects. Not usually performed in the situation of alcoholic cirrhosis or primary biliary cirrhosis.
(27 Sep 1997)
hepatic triad Branches of the portal vein, hepatic artery, and the biliary ducts bound together in the perivascular fibrous capsule or portal tract as they ramify within the substance of the liver.
Synonym: hepatic triad, triad.
(05 Mar 2000)
proper hepatic artery <anatomy, artery> Origin, common hepatic; branches, right and left hepatic.
Synonym: arteria hepatica propria.
(05 Mar 2000)
hepatic veins Veins which drain the liver.
(12 Dec 1998)
hepatic vein thrombosis Occlusion of the hepatic veins caused by thrombi or fibrous obliteration of the veins.
(12 Dec 1998)
hepatic veno-occlusive disease Blockage of the small- or medium-sized hepatic veins due to nonthrombotic subendothelial oedema which may progress to fibrosis.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á